Medicine & Life Sciences
Cyclophosphamide
100%
Graft vs Host Disease
70%
Transplantation
60%
Multiple Myeloma
50%
Transplants
44%
Haploidentical Transplantation
44%
Bone Marrow
44%
Chimeric Antigen Receptors
40%
B-Cell Maturation Antigen
29%
Cytokine Release Syndrome
28%
Recurrence
25%
T-Lymphocytes
24%
Survival
23%
Confidence Intervals
22%
Peripheral Blood Stem Cell Transplantation
21%
Homologous Transplantation
20%
Tissue Donors
19%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18%
Whole-Body Irradiation
17%
axicabtagene ciloleucel
16%
IQ motif containing GTPase activating protein 1
15%
Chimerism
15%
daratumumab
14%
Bone Marrow Transplantation
13%
Amyloidosis, Hereditary, Transthyretin-Related
13%
Protein-Tyrosine Kinases
13%
Pentostatin
13%
Incidence
12%
Plasmacytoma
11%
Peripheral T-Cell Lymphoma
11%
Thrombotic Microangiopathies
11%
Mortality
11%
Lenalidomide
11%
Hemophagocytic Lymphohistiocytosis
11%
Hemoglobinopathies
11%
Primary Myelofibrosis
10%
Prealbumin
10%
Sirolimus
10%
Esophageal and Gastric Varices
10%
Afatinib
9%
Cell- and Tissue-Based Therapy
9%
Amyloidosis
9%
Progression-Free Survival
9%
Unrelated Donors
9%
Granulocyte-Macrophage Colony-Stimulating Factor
9%
Clinical Trials
8%
Acute Myeloid Leukemia
8%
Lymphoma
8%
Immunosuppression
8%
Erlotinib Hydrochloride
8%